Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
This study reveals that Arid5a acts as an mTOR-independent translation facilitator and drives autoimmune CD4+ T cell responses.
Abstract
Naïve CD4+ T cells respond to antigenic stimulus and rapidly transition into active state by intensifying clonal expansion. To meet the bioenergetic demand for this energy-intensive process, CD4+ T cells modulate their transcriptional and translational regulatory mechanisms and fuel profound increase in protein production. However, unlike the transcriptional control, the translational layer of regulation that is at work and the molecular mechanisms underpinning the translational control in T cells remain elusive. AT-rich interactive domain 5a (ARID5a) is an unconventional RBP that primarily stabilizes the pro-inflammatory mRNA transcripts to drive the progression of autoimmune diseases such as EAE and rheumatoid arthritis. However, it remains completely unexplored whether Arid5a regulates protein synthesis in CD4+ T cells to drive autoimmune T cell-mediated responses.
Naive CD4+ T cells were activated from Wildtype and Arid5a-/- mice and the effect of Arid5a depletion on protein translation, proliferation and metabolism in T cells was assessed upon polyclonal CD4+ T cell activation as well as upon challenge with MOG- autoantigen. We used polysome profiling and molecular biology approaches to identify the mechanisms underlying the translational regulation by Arid5a.
We uncovered that Arid5a associated with translation initiation factors, eIF4G and poly A binding protein (PABP) to enhance the translation efficiency of Myc and drive CD4+ T cell expansion. Despite the central role of mTORC1 in controlling protein synthesis, the translational control-mediated by Arid5a was mTOR-independent, suggesting an underappreciated pathway of translational regulation in CD4+T cells. Deficiency of Arid5a disrupted Myc protein production and MOG autoantigen-specific CD4+ T cell proliferation.
Our study reveals that Arid5a acts as an mTOR-independent translation facilitator and drives autoimmune CD4+ T cell responses.
n/a
Immune Response Regulation: Molecular Mechanisms (IRM)
Naïve T cells maintain quiescence yet must respond rapidly to antigens, but how they prime this capacity is unclear. We identify histone variant H2A.Z as a key regulator of an epigenetic training program that licenses quiescent naïve CD8+ T cells for future activation. H2A.Z deficiency disrupts naïve T cell homeostasis...
Meng-Jie Lv, Ji-Yu Ding, Hai-Zhen Long et al.· Science Advances· 0 citations
Inflammatory disease is sustained not only by immune activation but also by the failure of activated cells to terminate effector programs and return tissues to homeostasis. This review evaluates N6-methyladenosine (m6A) as a post-transcriptional regulator of that persistence. Rather than cataloguing diseases or classif...
Yi-Zhang Zhu, Shiye Yang, Lei Qin et al.· Frontiers in Immunology· 0 citations
Inflammatory mediators are usually defined as extracellular signals, yet intracellular regulators determine which signals are converted into cell-specific, durable inflammatory programmes. Interferon regulatory factor 4 (IRF4) is a stringent test of this broader concept because its effects vary with abundance, partner...
Hui Zhang, Fang Cao, Jing-Hui Qian et al.· Frontiers in Immunology· 0 citations
The present study aimed to summarize the indispensable roles of interferon regulatory factors (IRFs) in CD8+ T cell biology from early thymic development to the acquisition of distinct functional states.
Fa-Xi Wang, Chun-Liang Yang, Shan-Jie Rong et al.· International Journal of Mol...· 1 citation
Chronic or persistent T cell activation is widely thought to culminate in T cell exhaustion, yet how autoreactive CD8⁺ T cells remain functionally intact despite sustained self-antigen exposure is poorly understood. In chronic infection and cancer this durability is attributed to stem-like, TCF1⁺ PD-1⁺ progenitor-exhau...
Kai-Yuan Hao, Sofia G. Baptista, Aurora Beaumond et al.· bioRxiv· 0 citations